Bigger revenues; smaller losses
Driven by gains in home HD with the System One cycler and the approval of nocturnal home HD, NxStage had higher revenues and smaller losses than expected for 2014—and has plans for an updated HD machine and PD.
Read the full article » | Posted 03-11-2015
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026

